These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 4122738)

  • 21. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of pulmonary tuberculosis.
    Johnston RF; Hopewell PC
    Ann Intern Med; 1969 Feb; 70(2):359-67. PubMed ID: 4974415
    [No Abstract]   [Full Text] [Related]  

  • 24. A pilot study of two regimens of intermittent thiacetazone plus isoniazid in the treatment of pulmonary tuberculosis in East Africa.
    Tubercle; 1974 Sep; 55(3):211-21. PubMed ID: 4143452
    [No Abstract]   [Full Text] [Related]  

  • 25. Short-course treatment in pulmonary tuberculosis.
    Jindani A
    East Afr Med J; 1975 Sep; 52(9):472-80. PubMed ID: 53135
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report. East and Central African/British Medical Research Council Fifth Collaborative Study.
    Tubercle; 1986 Mar; 67(1):5-15. PubMed ID: 3521015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].
    Ovchinnikova IuE; Starshinova AA; Dovgaliuk IF
    Probl Tuberk Bolezn Legk; 2009; (1):36-40. PubMed ID: 19256011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 30. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
    Tubercle; 1983 Sep; 64(3):153-66. PubMed ID: 6356538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report: Third East African/British Medical Research Councils study.
    Am Rev Respir Dis; 1978 Jul; 118(1):39-48. PubMed ID: 79319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Third East African/British Medical Research Council Study.
    Tubercle; 1980 Jun; 61(2):59-69. PubMed ID: 6159711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis Chemotherapy Centre, Madras.
    Tubercle; 1968 Mar; 49(1):114-21. PubMed ID: 4173465
    [No Abstract]   [Full Text] [Related]  

  • 35. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study.
    Am Rev Respir Dis; 1976 Sep; 114(3):471-5. PubMed ID: 788570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of acceptable and adequate outpatient treatment on the length of hospitalization and on readmission for relapse or reactivation of pulmonary tuberculosis.
    Curry FJ
    Chest; 1973 Apr; 63(4):536-46. PubMed ID: 4633013
    [No Abstract]   [Full Text] [Related]  

  • 39. New trends in the chemotherapy of tuberculosis--current aspects.
    Zierski M
    Pneumonologie; 1974 Jun; 150(1):1-12. PubMed ID: 4135222
    [No Abstract]   [Full Text] [Related]  

  • 40. Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.
    Balasubramanian R; Sivasubramanian S; Vijayan VK; Ramachandran R; Jawahar MS; Paramasivan CN; Selvakumar N; Somasundaram PR
    Tubercle; 1990 Dec; 71(4):253-8. PubMed ID: 2125153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.